Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets

MLA

Joshua R. Friedman, et al. “Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.” Gastroenterology, vol. 162, Mar. 2022, p. 828–843.e11. EBSCOhost, https://doi.org/10.1053/j.gastro.2021.11.015.

APA

Joshua R. Friedman, Ruixue Hou, Antonio Fabio Di Narzo, Ruiqi Huang, Marla Dubinsky, Mayte Suárez-Fariñas, Eduard Rogatsky, Carmen Argmann, Tetyana Dodatko, Bruce E. Sands, Ryan C. Ungaro, Frédéric M. Vaz, Mark Curran, Carrie Brodmerkel, Jacqueline Perrigoue, Ke Hao, Roman Kosoy, Phillip H. Comella, Wenhui Wang, … Eric E. Schadt. (2022). Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets. Gastroenterology, 162, 828–843.e11. https://doi.org/10.1053/j.gastro.2021.11.015

Chicago

Joshua R. Friedman, Ruixue Hou, Antonio Fabio Di Narzo, Ruiqi Huang, Marla Dubinsky, Mayte Suárez-Fariñas, Eduard Rogatsky, et al. 2022. “Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.” Gastroenterology 162 (March): 828–843.e11. doi:10.1053/j.gastro.2021.11.015.